SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (25658)9/22/1998 2:49:00 PM
From: bob zagorin  Read Replies (3) | Respond to of 32384
 
Thanks J.D.; very informative. I just seem to remember reading an analyst report that flagged some possible savings from the SRGN deal as LGND moved into the mfg. and sales arena. could be mistaken.



To: jayhawk969 who wrote (25658)9/23/1998 1:35:00 AM
From: Cheryl Galt  Read Replies (1) | Respond to of 32384
 
J.D.

Okay. Lilly will package ONTAK.

Will Lilly also manufacture it,
or is that done by Marathon?
or by Boston U ?

Also, how many SRGN shares were outstanding at the time of acquisition?

(I'm trying to finish my notes...)

TIA,
Cheryl

PS It's nice to come home late, and see Ligand at 9 again.

Hope it keeps rising, and never goes so low again ...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News